Foundation Medicine Gets New CEO

5/12/11Follow @xconomy

Cambridge, MA-based Foundation Medicine, the developer of genomic-based cancer diagnostics, said today it has named Michael Pellini as its new CEO. Pellini was previously the president of Clarient, a unit of GE Healthcare. He replaces Alexis Borisy, a partner at Third Rock Ventures who was Foundation’s original CEO. Borisy will remain on Foundation Medicine’s board as chairman.

By posting a comment, you agree to our terms and conditions.